Aytu BioPharma, Inc. (LON:0A8M)
London · Delayed Price · Currency is GBP · Price in USD 2.200
+0.520 (30.95%)
At close: May 16, 2025
Aytu BioPharma Cash Flow Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2016 - 2020 |
Net Income | -13.56 | -15.84 | -17.05 | -108.78 | -58.29 | Upgrade |
Depreciation & Amortization | 5.38 | 6.73 | 7.7 | 10.15 | 9.2 | Upgrade |
Other Amortization | 0.11 | 0.6 | 0.56 | - | - | Upgrade |
Asset Writedown & Restructuring Costs | 8.26 | - | 2.73 | 75.46 | 12.83 | Upgrade |
Stock-Based Compensation | 0.58 | 2.37 | 5.72 | 5.25 | 3.57 | Upgrade |
Provision & Write-off of Bad Debts | - | - | - | - | 0.61 | Upgrade |
Other Operating Activities | 2.78 | 6.06 | -5.17 | -0.03 | 4.44 | Upgrade |
Change in Accounts Receivable | -7.63 | 5.2 | -7.24 | 6.53 | 1.54 | Upgrade |
Change in Inventory | 0.38 | -4.82 | -3.49 | 1.3 | 2.79 | Upgrade |
Change in Accounts Payable | 0.29 | -2.08 | 3.09 | -7.68 | -3.25 | Upgrade |
Change in Other Net Operating Assets | 0.96 | -5.03 | 2.65 | -11.01 | 0.6 | Upgrade |
Operating Cash Flow | -1.94 | -1.39 | -5.13 | -28.82 | -25.96 | Upgrade |
Capital Expenditures | -0.23 | -0.33 | - | - | -2.34 | Upgrade |
Sale of Property, Plant & Equipment | 0.67 | - | - | - | - | Upgrade |
Cash Acquisitions | - | - | - | -3.18 | -0.48 | Upgrade |
Sale (Purchase) of Intangibles | -3 | - | - | - | - | Upgrade |
Other Investing Activities | - | - | -0.12 | -0.07 | 0.04 | Upgrade |
Investing Cash Flow | -2.56 | -0.33 | -0.12 | -3.25 | -2.78 | Upgrade |
Short-Term Debt Issued | 6.67 | 0.83 | - | - | 51.21 | Upgrade |
Long-Term Debt Issued | 1.86 | 13 | - | 15 | - | Upgrade |
Total Debt Issued | 8.53 | 13.83 | - | 15 | 51.21 | Upgrade |
Short-Term Debt Repaid | - | - | -2.25 | -4.12 | -53.98 | Upgrade |
Long-Term Debt Repaid | -1.86 | -15.72 | -0.1 | -16.1 | -0.97 | Upgrade |
Total Debt Repaid | -1.86 | -15.72 | -2.35 | -20.22 | -54.95 | Upgrade |
Net Debt Issued (Repaid) | 6.67 | -1.89 | -2.35 | -5.22 | -3.74 | Upgrade |
Issuance of Common Stock | 14.84 | 3.47 | 15.58 | 11.69 | 40.15 | Upgrade |
Other Financing Activities | -6.07 | -2.84 | -4.36 | -4.94 | -6.09 | Upgrade |
Financing Cash Flow | 15.44 | -1.26 | 8.87 | 1.53 | 30.31 | Upgrade |
Net Cash Flow | 10.95 | -2.98 | 3.63 | -30.54 | 1.57 | Upgrade |
Free Cash Flow | -2.17 | -1.72 | -5.13 | -28.82 | -28.31 | Upgrade |
Free Cash Flow Margin | -3.26% | -2.63% | -6.95% | -29.82% | -43.13% | Upgrade |
Free Cash Flow Per Share | -0.34 | -0.31 | -1.54 | -19.61 | -33.80 | Upgrade |
Cash Interest Paid | 2.82 | 4.04 | 3.81 | 3.15 | 1.25 | Upgrade |
Cash Income Tax Paid | 1.42 | 1.61 | - | - | - | Upgrade |
Levered Free Cash Flow | -9.49 | 3.92 | 5.56 | -17.72 | 15.64 | Upgrade |
Unlevered Free Cash Flow | -7.29 | 6.49 | 8.22 | -17.71 | 15.64 | Upgrade |
Change in Working Capital | -6 | -6.73 | -4.99 | -10.86 | 1.68 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.